MedCity News

Patient Group Sues AMA, Says the Org Shouldn’t Be Charging for CPT Codes

By Katie Adams

Health Tech, Consumer / Employer

Aligned Marketplace Secures $20M for Advanced Primary Care Marketplace

Venrock led Aligned Marketplace's Series A round. In total, the company has raised $31 million to date.

By Marissa Plescia

BioPharma, Pharma

Bristol Myers Squibb Protein Degrader Wins First-in-Class FDA Nod in Multiple Myeloma

Bristol Myers Squibb’s Zenbexus is the first FDA-approved drug in a new class of cancer drugs called CELMoDs. The pharma company is positioning this molecule as a successor to its legacy products for multiple myeloma.

By Frank Vinluan

MedCity Influencers

A group of nurses taking notes during a lecture at university.

Healthcare Keeps Buying AI. But Nobody’s Building the Workforce to Run It.

Most younger professionals entering the workforce have little visibility into interoperability, digital health infrastructure, or healthcare data architecture as career pathways.

By Rachel Dunscombe

Latest Video

Latest News

Providers, Policy, Payers, Legal

Corruption in the judiciary, the judge's gavel and euro banknotes in an envelope. Representation of corruption and bribery in the judiciary.

Appeals Court Sides with Providers in No Surprises Act Pay Dispute

A court ruling struck down key parts of how regulators calculate the No Surprises Act's qualifying payment amount, siding with the Texas Medical Association's argument that the formula has historically favored payers in arbitration.

By Katie Adams

Payers, Health Tech

Cotiviti Launches AI Solution to Address Coordination of Benefits Issues

Cotiviti launched an AI-powered coordination of benefits solution that uses enrollment data to identify and resolve coverage issues before claims are submitted.

By Marissa Plescia

Where Will AI Deployment Benefit Payers the Most?

We are taking a look at how health insurers are using AI, defining success, and managing cybersecurity risks. Give us your opinions by completing our brief, anonymous survey.

By MedCity News

BioPharma, Legal

PTC Therapeutics’ $211M Bid Wins Bankruptcy Auction for Sangamo Gene Therapy

Sangamo Therapeutics filed for Chapter 11 bankruptcy in June after its search for strategic alternatives failed to find a path forward for the company. PTC Therapeutics’ auction win brings a Sangamo gene therapy candidate for Fabry disease, a rare inherited disorder with few treatment options.

By Frank Vinluan

MedCity Influencers

Founders Should Stop Worrying If They’re “AI Enough”

In healthcare, enterprises are moving slower than the hype cycle would lead you to believe. That said, they’re not moving slowly – they are saying yes to AI, as long as it can solve for specific workflow needs.

By Blake Walker

Artificial Intelligence, Startups, Health Tech, Providers

New Startup Launches to Close the Bedside Communication Gap in Hospitals

The 1842 Fund launched a new startup called Suvi Health, which is developing an ambient AI platform that records hospital bedside conversations and turns them into a shared task list for patients and families. The company will pilot the tool with Mayo Clinic starting next month.

By Katie Adams

Consumer / Employer

Report: Employers’ Use of Big Three PBMs Falls in 2026

A new survey finds that employers are moving away from the Big Three PBMs while prioritizing healthcare affordability and transparency.

By Marissa Plescia

BioPharma, Startups

Startup Boulevard Bio Launches With Immune Reset Pioneer Schett as Co-Founder

Deerfield Management formed Boulevard Bio with scientific co-founders Georg Schett and Frank Nestle. The startup’s lead program is in early clinical development for an autoimmune kidney disorder, and could offer dosing advantages over a recently approved Vera Therapeutics medicine and a Vertex Pharmaceuticals drug currently under FDA review.

By Frank Vinluan

MedCity Influencers

Ambulatory Growth Demands a New Operating Model

While organizations have invested heavily in expanding ambulatory networks, many are discovering that operational workflows have not evolved at the same pace. The result is a growing gap between demand and the systems designed to manage it.

By Michelle Skinner

Health Tech, Providers

Health IT Vendor’s Data Breach Exposes Nearly 4M Patient Records

Revenue cycle vendor Unlimited Technology Systems disclosed a ransomware attack affecting 3.8 million patients — the second-largest healthcare data breach reported to HHS this year.

By Katie Adams

Health Tech

NOCD Announces Plans for National Expansion of Intensive Outpatient Therapy

NOCD, a virtual provider for OCD, announced plans to expand its virtual intensive outpatient program for people with severe OCD nationwide.

By Marissa Plescia

BioPharma, Pharma

Infinimmune Secures $75M for a More Human Approach to Developing Better Antibody Drugs

Immunology startup Infinimmune is developing antibody drugs with potential advantages over traditional monoclonal antibodies. The Series A financing will support two lead programs entering the clinic in atopic dermatitis.

By Frank Vinluan

MedCity Influencers

From Friction to Fix: Measuring What’s Breaking Payer-Provider Trust

Tolerance for this abrasion is gone. It wastes time, drains staff capacity, drives up costs, and affects the patient experience.

By Russ Thomas

Which Health Tech Companies Are Getting Customer Experience Right?

A new report from Forrester offers a score card assessing health tech vendors on customer experience for healthcare organizations considering adopting them.

By League and MedCity News

Devices & Diagnostics, Startups, Health Tech

How CMS Is Tackling ‘Coverage Purgatory’ for Medical Devices

CMS unveiled new details of its new RAPID pathway, which is designed to close the gap between FDA approval and Medicare coverage for breakthrough medical devices. Industry reaction has been largely positive, as medical device companies often sit in “coverage purgatory” for years.

By Katie Adams

Payers, BioPharma

Amazon Pharmacy Executive: Formularies are Anti-Choice

Tanvi Patel, vice president and general manager of Amazon Pharmacy, and her co-panelists at the recent Bullseye event, explained why PBMs, payers and doctors are all hampering consumer choice when it comes to patients getting affordable drugs.

By Arundhati Parmar